UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

Alteration of red blood cell microrheology by anti-tumor chemotherapy drugs

Biochemistry (Moscow). Supplement series A, Membrane and cell biology, 2016-04, Vol.10 (2), p.135-141

2016

Volltextzugriff (PDF)

Comparative efficiency and hemorheological consequences of hemotransfusion and epoetin therapy in anemic cancer patients

Clinical hemorheology and microcirculation, 2010, Vol.44 (2), p.115

2010

Volltextzugriff (PDF)

Albumin-bound paclitaxel (ab-pac) versus docetaxel for first-line treatment of metastatic breast cancer (MBC): Final overall survival (OS) analysis of a randomized phase II trial

Journal of clinical oncology, 2011-09, Vol.29 (27_suppl), p.275-275

2011

Volltextzugriff (PDF)

First-line phase Ib and II studies of picoplatin in combination with 5-fluorouracil and leucovorin (FOLPI) as a potential neuropathy-sparing therapy for colorectal cancer (CRC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.4100-4100

2008

Volltextzugriff (PDF)

A phase II study of picoplatin with docetaxel and prednisone in chemotherapy-naïve patients with metastatic hormone refractory prostate cancer (HRPC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.5153-5153

2008

Volltextzugriff (PDF)

Hemorheological changes in solid tumor patients after treatment with recombinant erythropoetin

Clinical hemorheology and microcirculation, 2009, Vol.41 (1), p.39

2009

Volltextzugriff (PDF)

Pharmacokinetic (PK) profile of quisinostat in combination with gemcitabine and cisplatin in patients (pts) with non-small cell lung cancer (NSCLC) or paclitaxel and carboplatin in pts with NSCLC or epithelial ovarian cancer

European journal of cancer (1990), 2017-02, Vol.72, p.S96-S96

2017

Volltextzugriff (PDF)

A Dose Finding Study of Weekly and Every-3-Week nab-Paclitaxel Followed by Carboplatin as First-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer

Journal of thoracic oncology, 2010-06, Vol.5 (6), p.852-861

2010

Volltextzugriff (PDF)

Results of a completed first-in-human phase Ib dose-escalation study of oral CBL0137 in patients with advanced solid tumors

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3607-3607

2020

Volltextzugriff (PDF)

Phase I dose of oral quisinostat, in combination with gemcitabine (G) and cisplatin (Cis) or paclitaxel (P) and carboplatin (Carbo) in patients (pts) with non-small cell lung cancer or ovarian cancer (OC)

Annals of oncology, 2016-10, Vol.27, p.vi123-vi123

2016

Volltextzugriff (PDF)

713 - Pharmacokinetic (PK) profile of quisinostat in combination with gemcitabine and cisplatin in patients (pts) with non-small cell lung cancer (NSCLC) or paclitaxel and carboplatin in pts with NSCLC or epithelial ovarian cancer

European journal of cancer (1990), 2017-02, Vol.72, p.S96-S96

2017

Volltextzugriff (PDF)

Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer

Annals of oncology, 2012-03, Vol.23 (3), p.589-597

2012

Volltextzugriff (PDF)

Abstract P6-11-02: Final Analysis of NO16853, a Randomized Phase II Non-Inferiority Study of Two Different Doses of Capecitabine in Combination with Docetaxel for Locally Advanced/Metastatic Breast Cancer (LA/MBC)

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P6-P6-11-02

2010

Volltextzugriff (PDF)

Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer

Annals of oncology, 2012-03, Vol.23 (3), p.589

2012

Volltextzugriff (PDF)

Unsteady shear vibrations of a die for a nonuniform base

Journal of Soviet Mathematics, 1992-06, Vol.60 (2), p.1374-1378

1992

Volltextzugriff (PDF)

The dynamics of structures on an elastic base

Journal of Soviet Mathematics, 1991-12, Vol.57 (5), p.3400-3402

1991

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(4)
Life Sciences & Biomedicine
(4)
Middle Aged
(4)
Science & Technology
(4)
Aged
(3)
Female
(3)
Adult
(2)
Anemia - Drug Therapy
(2)
Antineoplastic Combined Chemotherapy Protocols - Administration & Dosage
(2)
Erythropoietin - Therapeutic Use
(2)
Male
(2)
Neoplasms - Blood
(2)
Oncology
(2)
Recombinant Proteins
(2)
5-Fluorouracil
(1)
Abraxane
(1)
Aged, 80 And Over
(1)
Aggregation And Deformability
(1)
Albumin-Bound Paclitaxel
(1)
Albumins - Administration & Dosage
(1)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(4)
Annals Of Oncology
(3)
Clinical Hemorheology And Microcirculation
(2)
European Journal Of Cancer
(2)
Journal Of Soviet Mathematics
(2)
Biochemistry
(1)
Cancer Research
(1)
Journal Of Thoracic Oncology
(1)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Alteration of red blood cell microrheology by anti-tumor chemotherapy drugs

Comparative efficiency and hemorheological consequences of hemotransfusion and epoetin therapy in anemic cancer patients

Albumin-bound paclitaxel (ab-pac) versus docetaxel for first-line treatment of metastatic breast cancer (MBC): Final overall survival (OS) analysis of a randomized phase II trial

First-line phase Ib and II studies of picoplatin in combination with 5-fluorouracil and leucovorin (FOLPI) as a potential neuropathy-sparing therapy for colorectal cancer (CRC)

A phase II study of picoplatin with docetaxel and prednisone in chemotherapy-naïve patients with metastatic hormone refractory prostate cancer (HRPC)

Hemorheological changes in solid tumor patients after treatment with recombinant erythropoetin

Pharmacokinetic (PK) profile of quisinostat in combination with gemcitabine and cisplatin in patients (pts) with non-small cell lung cancer (NSCLC) or paclitaxel and carboplatin in pts with NSCLC or epithelial ovarian cancer

A Dose Finding Study of Weekly and Every-3-Week nab-Paclitaxel Followed by Carboplatin as First-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer

Results of a completed first-in-human phase Ib dose-escalation study of oral CBL0137 in patients with advanced solid tumors

Phase I dose of oral quisinostat, in combination with gemcitabine (G) and cisplatin (Cis) or paclitaxel (P) and carboplatin (Carbo) in patients (pts) with non-small cell lung cancer or ovarian cancer (OC)

713 - Pharmacokinetic (PK) profile of quisinostat in combination with gemcitabine and cisplatin in patients (pts) with non-small cell lung cancer (NSCLC) or paclitaxel and carboplatin in pts with NSCLC or epithelial ovarian cancer

Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer

Abstract P6-11-02: Final Analysis of NO16853, a Randomized Phase II Non-Inferiority Study of Two Different Doses of Capecitabine in Combination with Docetaxel for Locally Advanced/Metastatic Breast Cancer (LA/MBC)

Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer

Unsteady shear vibrations of a die for a nonuniform base

The dynamics of structures on an elastic base

Suchergebnisse filtern